Literature DB >> 29746228

Challenge of Proving the Value of Proton Therapy in an Unselected Patient Population in the Era of Precision Oncology: The Fallacy of a One-Size-Fits-All Strategy in Radiotherapy for Lung Cancer.

Ramesh Rengan1, Mary Redman1, Jing Zeng1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29746228     DOI： 10.1200/JCO.2018.78.3803

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Scanning Beam Proton Therapy versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and Outcomes.

Authors:  Zhenwei Zou; Stephen R Bowen; Hannah M T Thomas; Balu Krishna Sasidharan; Ramesh Rengan; Jing Zeng
Journal:  Adv Radiat Oncol       Date:  2020-03-20

2.  Clinical Outcomes After Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: Analysis of a Multi-institutional Prospective Registry.

Authors:  Aurélien Jongen; Florian Charlier; Kelsey Baker; John Chang; William Hartsell; George Laramore; Pranshu Mohindra; Luigi Moretti; Mary Redman; Lane Rosen; Henry Tsai; Dirk Van Gestel; Carlos Vargas; Ramesh Rengan
Journal:  Adv Radiat Oncol       Date:  2021-09-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.